Argentina: Severe COVID-19 patients treated with CoviFab horse serum show 90% less ICU need [View all]
Authorities from the Argentine pharmaceutical firm Inmunova released data today showing a 90% reduction in the need for intensive care in patients with severe COVID-19 symptoms who were treated with the firm's CoviFab equine serum.
Inmunova reported that 90% of 1805 COVID-19 patients as of April 26th - including 80% who had pneumonia and required oxygen - no longer required intensive care after treatment with CoviFab.
Fewer than 10% of the treated patients required Mechanical Respiratory Assistance (MRA), and the mortality rate observed among them was 8.9%.
Findings published in The Lancet's EClinicalMedicine journal on April 12th, among 245 patients in clinical trials from August through October 2020, a 44.5% mortality decline in severe cases was seen compared to the placebo group - as well as an improvement in recovery times.
Since its approval for public use by Argentina's FDA counterpart, ANMAT, in January, CoviFab equine serum has been used for over 3,000 Argentine COVID-19 patients in 54 hospitals in 17 provinces - predominantly severe cases.
“The use of treatment has increased dramatically,” Dr. Fernando Goldbaum, founding partner and scientific director at Inmunova, noted.
“We register its administration to 100 new patients every day. Buenos Aires Province (the nation's largest) distributes them in a massive way through its public hospitals, and in Córdoba it is beginning to be used on a greater scale.”
At: https://translate.google.com/translate?sl=es&tl=en&u=https://www.pagina12.com.ar/340700-el-exito-del-suero-equino-avanza-al-galope
Dr. Fernando Goldbaum, of the Argentine pharmaceutical firm Inmunova, studies a Petri dish with a fellow researcher in January.
Since Argentina's approval of Inmunova's CoviFab horse serum that month, over 3,000 mainly severe COVID-19 patients nationwide have received the treatment - with most showing substantial improvement.
The country is nevertheless struggling with 260,000 active cases - with around 20,000 new cases and 433 deaths daily.
= new reply since forum marked as read